معرفی
Professor Len Luyt serves as a faculty member in the Department of Chemistry at Western University, with cross-appointments in Oncology and Medical Imaging. His research laboratory is located at the London Regional Cancer Program (LRCP) within the Cancer Research Laboratories. Dr. Luyt leads an active research group focused on developing novel chemical entities for cancer imaging and therapy.
Dr. Luyt received his B.Sc.(Eng.) from Queen's University, followed by a Ph.D. in Chemistry from The University of Western Ontario under the mentorship of Prof. Duncan Hunter. He completed his postdoctoral fellowship with Prof. John Katzenellenbogen at the University of Illinois, Urbana-Champaign. Prior to joining Western University in 2005, he worked as a Senior Medicinal Chemist at Bayer-Schering.
His research program focuses on three primary areas: developing imaging agents targeting the ghrelin receptor (GHSR), exploring metal-organic compounds as scaffolds for biologically relevant chemical space, and creating peptide drugs that interfere with RHAMM:Hyaluronan interactions. His work bridges synthetic organic chemistry with molecular imaging and cancer therapeutics, specifically targeting peptide receptors on cancer tumor cells through radiolabeled compounds. The group develops compounds that can be used for positron emission tomography (PET) imaging and potential cancer treatments.
An analysis of Dr. Luyt's recent publications reveals a strong focus on molecular imaging agents, particularly for cancer diagnostics. His work spans multiple imaging modalities including PET, fluorescence, and SPECT imaging. A significant portion of his research targets the ghrelin receptor in prostate cancer, while other work explores novel chemical methodologies for radiolabeling peptides and developing metal-organic complexes for imaging applications. His research demonstrates a consistent trajectory from basic chemical synthesis through to applied preclinical studies.
- Innovator of the Year, Vanguard Awards (WorlDiscoveries)
- Early Researcher Award
Dr. Luyt actively mentors graduate students and postdoctoral fellows in his research laboratory. His group consists of multiple graduate students working on various aspects of cancer imaging agent development, including peptide synthesis, radiolabeling techniques, and biological evaluation. The research requires interdisciplinary collaboration with cancer biologists, imaging scientists, and clinicians to take projects from basic chemistry through to animal model studies. His laboratory at the London Regional Cancer Program provides students with training in synthetic organic chemistry, solid-phase organic chemistry, peptide/peptidomimetic design, bioconjugation, and radiolabeling techniques.
The Luyt Laboratory operates within the London Regional Cancer Program's Cancer Research Laboratories, providing state-of-the-art facilities for synthetic chemistry and radiopharmaceutical development. The research group collaborates extensively with other scientists at Western University and the Lawson Health Research Institute, creating a multidisciplinary environment focused on translating chemical discoveries into potential clinical applications for cancer imaging and therapy.
